Подсобите статьей:
Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine
Subhash C. Annedia, Shawn P. Maddaforda, Jailall Ramnautha, Paul Rentona,
European Journal of Medicinal Chemistry, Volume 55, September 2012, Pages 94–107
- DOI:
http://dx.doi.org//10.1016/j.ejmech.2012.07.006
